Global leader in liquid nitrogen storage systems expected to support growth, diversify revenue and reduce evo® manufacturing costs Preliminary 2020 revenue guidance of $50 - $56 Million Conference ...
BioLife Solutions, Inc. BLFS, a key player in bioproduction tools and services for cell and gene therapy (CGT) and the broader biopharma market, has unveiled its latest innovation, CryoCase, at the ...
Merit Medical Systems, Inc. has announced the acquisition of Biolife Delaware, L.L.C., which produces hemostatic devices under the StatSeal and WoundSeal brands. This strategic move is expected to ...
We have been happy that BioLife Solutions (BLFS) has gone back to basics and is concentrating (mostly) on what is its most important segment, the biopreservation media (which is 85% of its cell ...
BioLife Solutions, a leading provider of bioproduction tools and services, is poised for growth as the demand for biologics and regenerative medicine increases. CryoStor and HypoThermosol have shown ...